Delirium: A Frequent Manifestation in COVID-19 Older Patients by Mattace Raso, F.U.S. (Francesco) et al.
S H O RT  R E P O RT
Delirium: A Frequent Manifestation in COVID-19 
Older Patients
This article was published in the following Dove Press journal: 










Division of Geriatric Medicine, 
Department of Internal Medicine, 
Erasmus MC University Medical Center, 
Rotterdam, the Netherlands 
Abstract: The authors report a high prevalence of delirium in COVID-19 old patients 
admitted in an academic hospital. During the recent COVID-19 period, delirium was present 
in 38% of old patients admitted with delirium at the COVID ward of the Erasmus MC 
University Medical Center of Rotterdam. We do not know in which patients COVID-19 can 
cause delirium; however, considering the high prevalence of delirium in COVID-19 old 
patients and the potential serious consequences, attention is needed in order to reduce 
disability and mortality in this vulnerable category of patients. 
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From March until April 2020, 123 patients aged 60 years and older were admitted 
at the COVID ward of the Erasmus MC University Medical Center of Rotterdam, 
after the onset of coronavirus disease 2019 (COVID-19), the disease caused by 
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
During this period, 47 patients (38%), 37 men and 10 women, mean age 71.3 
years presented signs and symptoms of delirium. Of these, 39 patients developed 
a delirium during admission at the intensive care unit. Delirium screening was 
performed using the Delirium Observation Screening Scale (DOSS). A DOSS score 
≥3 suggesting a delirium, was followed by a delirium assessment by the ward 
physician according the DSM-5 criteria.1 At the ICU, the Intensive Care Delirium 
Screening Checklist (ICDSC), based on the DSM-5 criteria, is used 3 times daily 
for screening for delirium.2 Information on comorbidities was obtained from the 
medical records. Differences in baseline characteristics in patients with and without 
delirium were investigated by the analysis of covariance adjusted for age and sex, 
where appropriate (Table 1).
This prevalence of delirium is high in this novel disease which frequently 
presents with nasal secretions, cough, dyspnea, fever, myalgia, occasionally diar-
rhea and in about 15% of the patients with acute respiratory distress syndrome.
The high prevalence of delirium in COVID-19 patients at the ICU might be due 
to serious illness of these patients, the presence of traditional risk factors, but 
possibly also due to withdrawal of prolonged treatment with midazolam or cloni-
dine. Besides, severely ill COVID-19 patients develop thromboembolic episodes, 
myocardial damage, kidney and liver disease. It was reported that several patients 
with ARDS showed cerebral hypoperfusion or small acute ischemic strokes, even 
with no focal neurological signs.3 Neurological features such as Guillain–Barré 
syndrome are also described in COVID-19 positive patients;4 the virus can enter the 
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central nervous system and increase inflammatory cyto-
kines which can be expected to lead to delirium. With the 
activation of brain parenchymal cells, which might express 
inflammatory cytokines and other inflammatory mediators 
in the central nervous system, the inflammatory process 
can lead to neuronal and synaptic dysfunction which can 
be expected to lead to delirium.5
Another possible explanation could be the distinct pre-
sence of hypoxia in COVID-19 patients. Studies in surgical 
patients found a strong correlation between intraoperative 
O2 saturation and postoperative cognitive dysfunction.6 
Hypoxia and decreased brain oxygenation causes a failure 
in oxidative metabolism, which is associated with a strong 
release of neurotransmitters, especially glutamate and 
dopamine.7 The strong release of dopamine might explain 
the hyperactive form of delirium with agitation and hallu-
cinations. Hypoxia can also lead to reduced synthesis and 
release of acetylcholine. Cholinergic neurotransmission is 
sensitive to metabolic events, such as diminished 
availability of glucose and oxygen. Reduction in cerebral 
oxygen may induce delirium by impairing acetylcholine 
production.8
The prevalence of delirium reported in the present 
study is similar to the prevalence observed in other studies 
which have included patients of the same age but also 
older patients9,10 and is slightly higher than the prevalence 
of delirium (25–31%) reported in old patients admitted 
with non-COVID-19 pneumonia11,12 and in patients 
admitted with severe acute respiratory syndrome (SARS) 
and Middle East respiratory syndrome (MERS).13 At the 
moment we do not know in which patients COVID-19 can 
cause delirium; it might be speculated that decline in 
physiological capacity in organ systems, with an increased 
susceptibility to stressors such as frailty, can play a role in 
these vulnerable older persons. Frailty impairs organ 
reserves also at biomolecular level, due to inflammaging, 
immunosenescence, reduced oxygen uptake and altered 
energy balance which can be crucial in determining the 
onset of delirium in older vulnerable COVID-19 patients. 
Moreover, additional sensory and social deprivation, 
because of the specific care procedures associated with 
the treatment of this condition and extreme diminished, 
or lost, contact with relatives may have negative impact on 
the severity and duration of the delirium.
Delirium is an acute neuropsychiatric syndrome char-
acterized by disturbances in attention, awareness and cog-
nition – is a frequent disorder in older hospitalized 
patients. It is associated with poor clinical outcomes 
including prolonged hospital stay, loss of independence, 
admission in nursing homes and mortality. Considering the 
dramatic consequences of delirium and the high preva-
lence of delirium in COVID-19 older patients we must 
pay attention to early recognition of neuropsychiatric dis-
orders in order to start with delirium-related treatment to 
reduce disability and mortality in this vulnerable category 
of patients.
Ethics Statement
This study was conducted in accordance with the princi-
ples expressed in the Declaration of Helsinki. In The 
Netherlands, ethical approval and patient consent are not 
required for retrospective chart review studies in which 
data collected during routine clinical care are extracted and 
analyzed anonymously.
Disclosure
The authors report no conflicts of interest.
References
1. American Psychiatric Association. Diagnostic and Statistical Manual 
of Mental Disorders. 5th ed. Washington, DC; 2013.
2. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive care 
delirium screening checklist: evaluation of a new screening tool. 
Intensive Care Med. 2001;27:859–864. doi:10.1007/s001340100909
3. Combes A, Hajage D, Capellier G, et al. Extracorporeal membrane 
oxygenation for severe acute respiratory distress syndrome. New Engl 
J Med. 2018;378:1965–1975. doi:10.1056/NEJMoa1800385
4. Toscano G, Palmerini F, Ravaglia S, et al. Guillain-barre syndrome 
associated with SARS-CoV-2. N Engl J Med. 2020;382 
(26):2574–2576. doi:10.1056/NEJMc2009191
5. Maldonado JR. Delirium pathophysiology: an updated hypothesis of 
the etiology of acute brain failure. Int J Geriatr Psychiatry. 
2018;33:1428–1457. doi:10.1002/gps.4823
6. Morimoto Y, Yoshimura M, Utada K, Setoyama K, Matsumoto M, 
Sakabe T. Prediction of postoperative delirium after abdominal surgery 
in the elderly. J Anesth. 2009;23:51–56. doi:10.1007/s00540-008- 
0688-1
Table 1 Characteristics of Patients with and without Delirium
Delirium 
n=47
No Delirium n= 
76
p-value
Age (years) 71.3 70.4 ns
Women (%) 10 (21.3) 25 (33) ns
Hypertension (%) 24 (51) 25 (32) ns
Diabetes Mellitus 
(%)
12 (25.5) 19 (25) ns
Previous Stroke 5 (10.6) 7 (9.2) ns
Admission ICU 39 (83) 31 (40.8) 0.001
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